Drug intelligence / Profile preview

Gynura pseudochina var. hispida

Development stage: Unknown
Administration: Topical, Oral

Overview

Gynura pseudochina var. hispida is a medicinal plant from the Asteraceae family traditionally used in Thailand for treating chronic and acute inflammation. It contains bioactive compounds that inhibit the NF-κB pathway and suppress pro-inflammatory cytokines. The plant has demonstrated clinical efficacy in treating mild to moderate psoriasis with minimal side effects, comparable to 0.1% triamcinolone cream. However, caution is advised due to potential presence of hepatotoxic pyrrolizidine alkaloids.

Other names: Gynura pseudochina DC. var. hispida Thv.Gynura pseudochina (L.) var. hispida Thv.

Targets

NF-κB

Beyond the preview

Go deeper on Gynura pseudochina var. hispida.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gynura pseudochina var. hispida.

Explore the full profile